zacks.com / .zacks-com / Page 6

SR gains from infrastructure upgrades, rising capex and customer growth, but faces risks due to financial reliance on subsidiaries.

ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.

GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

STN has surged 39% YTD on strong demand and rising margins. But is its premium valuation flashing caution?

SHEL and BP partner with Libya's NOC to explore and develop hydrocarbon potential across three key oilfields, marking a return to the energy-rich nation.

Progyny (PGNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

TMUS, AZN, and CMCSA show diverging paths as 5G gains, pipeline growth, and streaming resilience shape their outlooks.

CCL, MANU, MCS, MSGS, and PRSU ride a leisure boom with strong earnings growth, rising bookings, and bullish analyst targets.

STKS and LGCY are flashing bullish signals as earnings momentum, valuations, and technicals align for breakout moves.